2641899-38-7

2641899-38-7 structure
2641899-38-7 structure
  • Name: FD274
  • Chemical Name: FD274
  • CAS Number: 2641899-38-7
  • Molecular Formula: C22H14ClFN6O2S
  • Molecular Weight: 480.90
  • Catalog: Signaling Pathways PI3K/Akt/mTOR mTOR
  • Create Date: 2023-10-20 09:49:54
  • Modify Date: 2024-01-06 13:45:50
  • FD274 is a highly potent PI3K/mTOR dual inhibitor with IC50s of 0.65 nM, 1.57 nM, 0.65 nM, 0.42 nM, and 2.03 nM against PI3Kα/β/γ/δ and mTOR, respectively. FD274 exhibits significant anti-proliferation of AML cell lines (HL-60 and MOLM-16). FD274 demonstrates dose-dependent inhibition of tumor growth in the HL-60 xenograft model. FD274 has the potential for acute myeloid leukemia research[1].

Name FD274
Description FD274 is a highly potent PI3K/mTOR dual inhibitor with IC50s of 0.65 nM, 1.57 nM, 0.65 nM, 0.42 nM, and 2.03 nM against PI3Kα/β/γ/δ and mTOR, respectively. FD274 exhibits significant anti-proliferation of AML cell lines (HL-60 and MOLM-16). FD274 demonstrates dose-dependent inhibition of tumor growth in the HL-60 xenograft model. FD274 has the potential for acute myeloid leukemia research[1].
Related Catalog
Target

PI3Kα:0.65 nM (IC50)

PI3Kβ:1.57 nM (IC50)

PI3Kδ:0.65 nM (IC50)

PI3Kγ:0.42 nM (IC50)

mTOR:2.03 nM (IC50)

References

[1]. Chengbin Yang, et al. Discovery of N-(2-chloro-5-(3-(pyridin-4-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl)pyridin-3-yl)-4-fluorobenzenesulfonamide (FD274) as a highly potent PI3K/mTOR dual inhibitor for the treatment of acute myeloid leukemia. Eur J Med Chem. 2023 Oct 5;258:115543.  

Molecular Formula C22H14ClFN6O2S
Molecular Weight 480.90